Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: A preliminary dose escalating toxicity study

Leo B. Twiggs, Roger A. Potish, Susan McIntyre, Leon L. Adcock, John E. Savage, Konald A. Prem

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Concurrent weekly cis-platinum in a dose escalating manner and conventional radiotherapy was evaluated in advanced cervical cancer. The toxicity of weekly cis-platinum given 2 hr before standard fractionation of radiotherapy was assessed using the modified GOG toxicity criteria. Sixteen patients having parameters indicating high risk for conventional therapy failure including positive pelvic and paraaortic nodes and intraperitoneal spread were entered. There was no life-threatening toxicity. The toxicity of the administered chemotherapy was only moderate. Patient compliance was good as at the 20 mg/m2 dose level, 79% of the prescribed doses were administered. The use of adjuvant cis-platinum in poor prognosis advanced cervical cancer merits further study.

Original languageEnglish (US)
Pages (from-to)143-148
Number of pages6
JournalGynecologic oncology
Volume24
Issue number2
DOIs
StatePublished - Jun 1986

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: A preliminary dose escalating toxicity study'. Together they form a unique fingerprint.

  • Cite this